AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.670
-0.040 (-1.48%)
At close: Nov 20, 2024, 4:00 PM
2.630
-0.040 (-1.50%)
Pre-market: Nov 21, 2024, 4:59 AM EST
AbCellera Biologics Employees
AbCellera Biologics had 586 employees as of December 31, 2023. The number of employees increased by 91 or 18.38% compared to the previous year.
Employees
586
Change (1Y)
91
Growth (1Y)
18.38%
Revenue / Employee
$56,249
Profits / Employee
-$299,995
Market Cap
788.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Dec 31, 2020 | 206 | 99 | 92.52% |
| Dec 31, 2019 | 107 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Healthcare Services Group | 33,400 |
| Cytek Biosciences | 676 |
| Castle Biosciences | 610 |
| Autolus Therapeutics | 471 |
| Relay Therapeutics | 323 |
| Evolus | 273 |
| Capricor Therapeutics | 102 |
ABCL News
- 13 days ago - AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 - Business Wire
- 16 days ago - AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - AbCellera Reports Q3 2024 Business Results - Business Wire
- 4 weeks ago - AbCellera to Present at Upcoming Investor Conferences in November 2024 - Business Wire
- 5 weeks ago - AbCellera: A Platform To Pipeline Transition - Seeking Alpha
- 6 weeks ago - AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 - Business Wire
- 7 weeks ago - AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 - Business Wire
- 2 months ago - AbCellera to Present at Upcoming Investor Conferences in September - Business Wire